Publications

Year

2023　 2022　 2021　 2020　 2019　 2018　 2017　 2016　 Before 2015

2023

  1. Horie M *, Tanaka H, Suzuki M, Sato Y, Takata S, Takai E, Miyashita N, Saito A, Nakatani Y, Yachida S. An integrative epigenomic approach identifies ELF3 as an oncogenic regulator in ASCL1-positive neuroendocrine carcinoma. , Tanaka H, Suzuki M, Sato Y, Takata S, Takai E, Miyashita N, Saito A, Nakatani Y, Yachida S.Cancer Sci. 2023. Online ahead of print.
  2. Tanaka H, Uno A, Takenaka Y, Suzuki M, Seo Y, Takemoto N, Fukusumi T, Eguchi H, Kanai H, Horie M , Isohashi F, Ogawa K, Yachida S, Inohara H. Clearance Profile of Circulating Tumor Human Papillomavirus DNA During Radiotherapy Predicts Clinical Outcomes in Human Papillomavirus-Related Oropharyngeal Cancer.JCO Precis Oncol. 2023. Online ahead of print.
  3. Umakoshi M, Nakamura A, Tsuchie H, Li Z, Kudo-Asabe Y, Miyabe K, Ito Y , Yoshida M, Nagasawa H, Okada K, Nanjo H, Maeda D , Miyakoshi N, Tanaka M, Goto A.Macrophage numbers in the marginal area of sarcomas predict clinical prognosis. Sci Rep. 1290;13:2023.

2022

  1. Yachida S, Totoki Y, Noë M, Nakatani Y, Horie M *, Kawasaki K, Nakamura H, Saito-Adachi M, Suzuki M, Takai E, Hama N, Higuchi R, Hirono S, Shiba S, Kato M, Furukawa E , Arai Y, Rokutan H, Hashimoto T, Mitsunaga S, Kanda M, Tanaka H, Takata S, Shimomura A, Oshima M, Hackeng WM, Okumura T, Okano K, Yamamoto M, Yamaue H, Morizane C, Arihiro K, Furukawa T, Sato T, Kiyono T, Brosens LAA, Wood LD, Hruban RH, Shibata T. Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System. Cancer Discov. 692-711;12:2022.
  2. Takata S, Miyake K, Maeda D , Hatake K, Nagatomo I, Shiroyama T, Masuhiro K, Yaga M, Shirai Y, Mitsui Y, Yachida S, Kumanogoh A.Proposal of a novel pipeline involving precise bronchoscopy of distal peripheral pulmonary lesions for genetic testing. Sci Rep. 19774;12:2022.
  3. Minerva D, Othman NL, Nakazawa T, Ito Y , Yoshida M, Goto A, Suzuki TA New Chemotactic Mechanism Governs Long-Range Angiogenesis Induced by Patching an Arterial Graft into a Vein.Int J Mol Sci. 11208;23:2022.
  4. Ino D, Tanaka Y , Hibino H, Nishiyama MA fluorescent sensor for real-time measurement of extracellular oxytocin dynamics in the brain. Nat Methods. 10;1286-1294:2022.
  5. Takano C, Horie M , Taiko I, Trinh QD, Kanemaru K, Komine-Aizawa S, Hayakawa S, Miki T.Inhibition of Epithelial-Mesenchymal Transition Maintains Stemness in Human Amniotic Epithelial Cells.Stem Cell Rev Rep. 3038-3091;18 :2022
  6. Oyama S, Ohuchi S, Arai T, Ito Y .Chronic contained rupture of abdominal aortic aneurysm that developed from chronic abdominal aortic dissection. Journal of Vascular Surgery Cases and Innovative Techniques7;280-282:2022.
  7. Miyakawa K, Miyashita N, Horie M , Terasaki Y, Tanaka H, Urushiyama H, Fukuda K, Okabe Y, Ishii T, Kuwahara N, Suzuki HI, Nagase T, Saito A. ASCL1 regulates super-enhancer-associated miRNAs to define molecular Subtypes of small cell lung cancer. Cancer Sci. 3932-3946;113:2022.
  8. Akiyama Y, Miyakawa J, O'Donnell MA, Kreder KJ, Luo Y, Maeda D , Ushiku T, Kume H, Homma Y. Overexpression of HIF1α in Hunner Lesions of Interstitial Cystitis: Pathophysiological Implications. J Urol. :2022.

2021

  1. Ito Y , Minerva D, Tasaki S, Yoshida M, Suzuki T, Goto A.Time Changes in the VEGF-A Concentration Gradient Lead Neovasculature to Engage in Stair-Like Growth. Springer Proceedings in Mathematics and Statistics.370;226-234: 2021.
  2. Kito M, Maeda D *, Kudo-Asabe Y, Tamura D, Makino K, Sageshima M, Nanjo H, Terada Y, Goto A. Detection of MED12 mutations in mesenchymal components of uterine adenomyomas. Hum Pathol. 109;31-36: 2021.
  3. Halimi SA, Maeda D *, Ushiku-Shinozaki A, Goto A, Oda K, Osuga Y, Fujii T, Ushiku T, Fukayama M. Comprehensive immunohistochemical analysis of the gastrointestinal and Müllerian phenotypes of 139 ovarian mucinous cystadenomas. Hum Pathol. 21-30: 2021.
  4. Ito Y , Yoshida M, Masuda H, Maeda D , Kudo-Asabe Y, Umakoshi M, Nanjo H, Goto A. Disorganization of intercalated discs in dilated cardiomyopathy. Sci Rep. 11;11852:2021.
  5. Nakamura R, Oyama T , Inokuchi M, Ishikawa S, Hirata M, Kawashima H, Ikeda H, Dobashi Y, Ooi A. Neural EGFL like 2 expressed in myoepithelial cells and suppressed breast cancer cell migration. Pathol Int. 71;326-336 :2021.
  6. Inagaki C, Maeda D , Hatake K, Sato Y, Hashimoto K, Sakai D, Yachida S, Nonomura N, Satoh T. Clinical Utility of Next-Generation Sequencing-Based Panel Testing under the Universal Health-Care System in Japan: A Retrospective Analysis at a Single University Hospital. Cancers (Basel). 13;1121:2021.
  7. Tamura D, Maeda D , Enomoto K, Sato H. Severe Abdominal Recurrence of Low-grade Endometrial Stromal Sarcoma After Hysteroscopic Surgery. Anticancer Res. 41;4013-4016:2021.
  8. Suzuki M, Saito-Adachi M, Arai Y, Fujiwara Y, Takai E, Shibata S, Seki M, Rokutan H, Maeda D , Horie M , Suzuki Y, Shibata T, Kiyono T, Yachida S. E74-Like Factor 3 Is a Key Regulator of Epithelial Integrity and Immune Response Genes in Biliary Tract Cancer. Cancer Res. 81;489-500:2021.
  9. Miyabe K, Saito M, Koyama K, Umakoshi M, Ito Y , Yoshida M, Kudo-Asabe Y, Saito K, Nanjo H, Maeda D , Matsusaka K, Goto A, Kono K. Collision of Epstein-Barr virus-positive and -negative gastric cancer, diagnosed by molecular analysis: a case report. BMC Gastroenterol. 21;97:2021.
  10. Yorozu T, Nagahama K, Morii T, Maeda D , Yoshida A, Mori T, Hayashi A, Shibahara J. Myoepithelioma-like Hyalinizing Epithelioid Tumor of the Foot Harboring an OGT-FOXO1 Fusion. Am J Surg Pathol. :2021.
  11. Akiyama Y, Yao JR, Kreder KJ, O'Donnell MA, Lutgendorf SK, Lyu D, Maeda D , Kume H, Homma Y, Luo Y. Autoimmunity to urothelial antigen causes bladder inflammation, pelvic pain, and voiding dysfunction: a novel animal model for Hunner-type interstitial cystitis. Am J Physiol Renal Physiol. 320;F174-F182:2021.

2020

  1. Ito Y , Yoshida M, Sugiyama T, Masuda H, Mori M, Kimura N, Umakoshi M, Miyabe K, Kudo-Asabe Y, Goto A. Multiple ulcerations and perforation in the small intestine after steroid treatment in eosinophilic granulomatosis with polyangiitis: a Cardiovascular Pathology 47;107193: 2020.
  2. Koyama K, Maeda D *, Kito M, Tamura D, Kudo-Asabe Y, Katoh H, Ishikawa S, Nanjo H, Terada Y, Goto A. Clinicopathological and molecular analyzes of linearly expanded epithelial cells with β-catenin alterations, "β -catenin signature", in the normal fallopian tube. Histopathology .77;880-889:2020.
  3. Takai E, Maeda D *, Li Z, Kudo-Asabe Y, Totoki Y, Nakamura H, Nakamura A, Nakamura R, Kirikawa M, Ito Y , Yoshida M, Inoue T, Habuchi T, Ikoma S, Katoh H, Kato M , Shibata T, Ishikawa S, Yachida S, Goto A.Post-mortem Plasma Cell-Free DNA Sequencing: Proof-of-Concept Study for the "Liquid Autopsy". Sci Rep. 10;2120:2020.
  4. Nomura Y, Tamura D, Horie M , Sato M, Sasaki S, Yamamoto Y, Kudo-Asabe Y, Umakoshi M, Koyama K, Makino K, Takashima S, Imai K, Minamiya Y, Munakata S, Yachida S, Terada Y, Goto A, Maeda D *. Detection of MEAF6-PHF1 translocation in an endometrial stromal nodule. Genes Chromosomes Cancer. 58;702-708:2020.
  5. Nakamura R, Oyama T , Inokuchi M, Ishikawa S, Hirata M, Kawashima H, Ikeda H, Dobashi Y, Ooi A The relation between anti-TGBFR1 immunohistochemical reaction and low Ki67, small tumor size and high estrogen receptor expression in invasive breast cancer .Pathol Int. 70;330-339:2020.
  6. Tamura D, Maeda D , Sato T, Sugawara T, Shirasawa H, Shimizu D, Sato N, Goto A, Terada Y. An extragonadal yolk sac tumor presumed to be of postmeiotic germ cell origin by genetic zygosity analysis via single nucleotide polymorphism array. Genes Chromosomes Cancer. 59;209-213:2020.
  7. Baba S, Taguchi A, Kawata A, Hara K, Eguchi S, Mori M, Adachi K, Mori S, Iwata T, Mitsuhashi A, Maeda D , Komatsu A, Nagamatsu T, Oda K, Kukimoto I, Osuga Y, Fujii T , Kawana K. Differential expression of human papillomavirus 16-, 18-,52-, and 58-derived transcripts in cervical intraepithelial neoplasia. Virol J. 17;32:2020.
  8. Homma Y, Akiyama Y, Tomoe H, Furuta A, Ueda T, Maeda D, Lin AT, Kuo HC, Lee MH, Oh SJ, Kim JC, Lee KS.Clinical guidelines for interstitial cystitis/bladder pain syndrome.Int J Urol. 27;578-589:2020.
  9. Zheng J, Guo X, Shioya A, Yoshioka T, Matsumoto K, Hiraki T, Kusano H, Oyama T , Kurose N, Yamaguchi R, Uramoto H, Ieiri S, Okajima H, Kohno M, Yamada S. Peroxiredoxin 4 promotes embryonal hepatoblastoma Cell migration but induces fetal cell differentiation. Am J Transl Res. 12;2726-2737:2020

2019

  1. Akiyama Y, Maeda D , Katoh H, Morikawa T, Niimi A, Nomiya A, Sato Y, Kawai T, Goto A, Fujimura T, Fukuhara H, Nakagawa T, Igawa Y, Ishikawa S, Fukayama M, Kume H, Homma Y .Molecular Taxonomy of Interstitial Cystitis/Bladder Pain Syndrome Based on Whole Transcriptome Profiling by Next-Generation RNA Sequencing of Bladder Mucosal Biopsies. J Urol. 202;290-300:2019.
  2. Umakoshi M, Takahashi S, Itoh G, Kuriyama S, Sasaki Y, Yanagihara K, Yashiro M, Maeda D , Goto A, Tanaka M.Macrophage-mediated transfer of cancer-derived components to stromal cells contributes to establishment of a pro-tumor Microenvironment. Oncogene. 38;2162-2176:2019.
  3. Terakawa H, Gabata R, Ishikawa S, Hirata M, Inokuchi M, Kawashima H, Miyashita T, Tajima H, Takamura H, Ninomiya I, Fushida S, Ohta T, Oyama T , Ikeda HA Case of Histiocytoid Breast Carcinoma Accompanied by Multiple Axillary Lymph Node Metastases. Gan To Kagaku Ryoho. 46;1049-1051:2019.
  4. Ooi A, Inokuchi M, Horike SI, Kawashima H, Ishikawa S, Ikeda H, Nakamura R, Oyama T , Dobashi Y. Amplicons in breast cancers analyzed by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization. Hum Pathol. 85; 33-43:2019.

2018

  1. Ito Y , Yoshida M, Maeda D , Takahashi M, Nanjo H, Masuda H, Goto A.Neovasculature can be induced by patching an arterial graft into a vein: A novel in vivo model of spontaneous arteriovenous fistula formation. Sci Rep. 8; 3156: 2018.
  2. Tamura D, Maeda D *, Halimi SA, Okimura M, Kudo-Asabe Y, Ito S, Sato N, Shibahara J, Nanjo H, Terada Y, Goto A. Adenomatoid tumor of the uterus is frequently associated with iatrogenic immunosuppression. Histopathology. 73:1013-1022:2018.
  3. Li Z, Maeda D *, Kudo-Asabe Y, Tamura D, Nanjo H, Hayashi A, Ikemura M, Fukayama M, Goto A. MED12 is frequently mutated in ovarian and other adnexal leiomyomas. Hum Pathol. 81:89-95: 2018.
  4. Akiyama Y, Maeda D *, Morikawa T, Niimi A, Nomiya A, Yamada Y, Igawa Y, Goto A, Fukayama M, Homma Y. Digital quantitative analysis of mast cell infiltration in interstitial cystitis. Neurourol Urodyn. : 2018.
  5. Tsuda T, Tada H, Tanaka Y, Nishida N, Yoshida T, Sawada T, Sakata K, Hayashi K, Kawashiri MA, Oyama T , Sasaki M, Kurose N, Yamagishi M. Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports J Med Case Rep. 12:95:2018.
  6. Ooi A, Oyama T Detection of CCND1 Gene Copy Number Variations Using Multiplex Ligation-Dependent Probe Amplification and Fluorescence In Situ Hybridization Methods.Methods Mol Biol. 1726;101-109:2018.
  7. Li Z, Maeda D , Yoshida M, Umakoshi M, Nanjo H, Shiraishi K, Saito M, Kohno T, Konno H, Saito H, Minamiya Y, Goto A.The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer. Lung Cancer. 123;127-135:2018.

2017

  1. Ito Y , Maeda D *, Yoshida M, Yoshida A, Kudo-Asabe Y, Nanjyo H, Izumi C, Yamamoto F, Inoue M, Shibata H, Katoh H, Ishikawa S, Nakamura H, Totoki Y, Shibata T, Yachida S , Goto A. Cardiac intimate sarcoma with PDGFRβ mutation and co-amplification of PDGFRα and MDM2: an autopsy case analyzed by whole-exome sequencing. Virchows Arch. 471:423-428:2017.
  2. Koyama K, Maeda D *, Tamura D, Narita C, Kudo-Asabe Y, Sato T, Yamamoto Y, Sageshima M, Nanjo H, Goto A. Fetal Gut-Like Differentiation in Gallbladder Cancer. Hum Pathol. 70:27-34 : 2017.
  3. Goto K, Maeda D *, Kudo-Asabe Y, Hibiya T, Hayashi A, Fukayama M, Ohashi K, Goto A. PIK3CA and AKT1 mutations in hidradenoma papilliferum. J Clin Pathol. 70:424-427:2017.
  4. Tanaka M, Kuriyama S, Itoh G, Maeda D , Goto A, Tamiya Y, Yanagihara K, Yashiro M, Aiba N. Mesothelial Cells Create a Novel Tissue Niche That Facilitates Gastric Cancer Invasion. Cancer Res. 77:684-695:2017 .

2016

  1. Kito M, Maeda D *, Kudo-Asabe Y, Sato N, Shih IeM, Wang TL, Tanaka M, Terada Y, Goto A. Expression of Cell Competition Markers at the Interface between p53 Signature and Normal Epithelium in the Human Fallopian Tube. PLoS One. 11:e0156069, 2016.
  2. Shiraishi K, Okada Y, Takahashi A, Kamatani Y, Momozawa Y, Ashikawa K, Kunitoh H, Matsumoto S, Takano A, Shimizu K, Goto A, Tsuta K, Watanabe S, Ohe Y, Watanabe Y, Goto Y, Nokihara H , Furuta K, Yoshida A, Goto K, Hishida T, Tsuboi M, Tsuchihara K, Miyagi Y, Nakayama H, Yokose T, Tanaka K, Nagashima T, Ohtaki Y, Maeda D , Imai K, Minamiya Y, Sakamoto H, Saito A, Shimada Y, Sunami K, Saito M, Inazawa J, Nakamura Y, Yoshida T, Yokota J, Matsuda F, Matsuo K, Daigo Y, Kubo M, Kohno T. Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma. Nat Commun. 7:12451,2016.
  3. Tanaka M, Shimamura S, Kuriyama S, Maeda D , Goto A, Aiba N.SKAP2 Promotes Podosome Formation to Facilitate Tumor-Associated Macrophage Infiltration and Metastatic Progression. Cancer Res. 76:358-69,2016.

Before 2015

  1. Maeda D *, Akiyama Y, Morikawa T, Kunita A, Ota Y, Katoh H, Niimi A, Nomiya A, Ishikawa S, Goto A, Igawa Y, Fukayama M, Homma Y.Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation. PLoS One. 10:e0143316:2015.
  2. Tanaka Y, Sakata K, Waseda Y, Fujimura T, Yamada K, Oyama T , Kawashiri MA, Yamagishi M. Xiphodynia Mimicking Acute Coronary Syndrome. Intern Med. 2015;54:1563-6.
  3. Halimi SA, Maeda D *, Shinozaki-Ushiku A, Koso T, Matsusaka K, Tanaka M, Arimoto T, Oda K, Kawana K, Yano T, Fujii T, Fukayama M.Claudin-18 overexpression in intestinal-type mucinous borderline tumour of the ovary. Histopathology. 63:534-44:2013.
  4. Maeda D , Shibahara J, Sakuma T, Isobe M, Teshima S, Mori M, Oda K, Nakagawa S, Taketani Y, Ishikawa S, Fukayama M.β-catenin (CTNNB1) S33C mutation in ovarian microcystic stromal tumors. Am J Surg Pathol. 35:1429-40:2011.
  5. Maeda D , Ota S, Takazawa Y, Ohashi K, Mori M, Imamura T, Nakagawa S, Yano T, Taketani Y, Fukayama M.Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases Virchows Arch. 457:597-608:2010.
  6. Maeda D , Mao TL, Fukayama M, Nakagawa S, Yano T, Taketani Y, Shih IeM.Clinicopathological significance of loss of ARID1A immunoreactivity in ovarian clear cell carcinoma. Int J Mol Sci. 11:5120-8:2010.
  7. Yoshida M, Sho E, Nanjo H, Takahashi M, Kobayashi M, Kawamura K, Honma M, Komatsu M, Sugita A, Yamauchi M, Hosoi T, Ito Y , Masuda H.Weaving hypothesis of cardiomyocyte sarcomeres: Discovery of periodic broadening and narrowing of intercalated disk during volume-load change. American Journal of Pathology. 176;660-678:2010.
  8. Maeda D , Ota S, Takazawa Y, Aburatani H, Nakagawa S, Yano T, Taketani Y, Kodama T, Fukayama M. Glypican-3 expression in clear cell adenocarcinoma of the ovary. Mod Pathol. 22:824-32:2009.
  9. Maeda D , Ota S, Ikeda S, Kawano R, Hata E, Nakajima J, Mori M, Fukayama M. Mucinous adenocarcinoma of the thymus: a distinct variant of thymic carcinoma. Lung Cancer. 64:22-7:2009.